BioSpace News Archive

Pharm Country

Organoids Market with Competitive Analysis, New Business Developments with Key Players Hubrecht Organoid Technology (Hub), Cellesce Ltd., Definigen

The global organoids Market is a fragmented landscape with several new players driving intense competition and rising investment in innovation.

March 16, 2020
·
4 min read
Drug Development

A Paper Raises Some Safety Concerns for Gilead’s COVID-19 Treatment

As the world waits with bated breath for a treatment for COVID-19, all eyes are on Gilead Science’s antiviral drug remdesivir as a potential candidate.

March 16, 2020
·
2 min read
·
Alex Keown
Deals

AcelRx Buys Tetraphase Pharma for $14.4 Million

AcelRx Pharmaceuticals, headquartered in Redwood City, California, is buying Watertown, Massachusetts-based TetraPhase Pharmaceuticals for $14.4 million.

March 16, 2020
·
3 min read
·
Mark Terry
Deals

Hua Medicine Announces 2019 Annual Results

Hua Medicine, a global innovative drug research and development company focused on novel therapies for the treatment of diabetes, announces the audited consolidated results of the Company and its subsidiaries for the year ended December 31, 2019.

March 16, 2020
·
7 min read
Business

BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China

BioNTech and Fosun Pharma will jointly conduct clinical trials of BNT162 in China, leveraging BioNTech’s proprietary mRNA vaccine technology and Fosun Pharma’s clinical development and commercialization capabilities in China

March 16, 2020
·
5 min read
BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat

BioNTech SE provides further details on the Company’s R&D effort, “Project Lightspeed”, to develop a potential vaccine to induce immunity and prevent COVID-19 infection in response to the growing global health threat posed by the disease.

March 16, 2020
·
5 min read
BioMidwest

Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control

New reference material aims to facilitate and expedite global efforts to detect the novel coronavirus

March 16, 2020
·
2 min read
Business

Arvinas Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate update.

March 16, 2020
·
12 min read
XORTX Launches XRx-101, A New Program to Treat Coronavirus COVID-19 Infection

XORTX Therapeutics Inc. announces that it is exploring the potential of using XRx-101 (a new formulation of Oxypurinol) as a novel treatment for acute kidney and lung

March 16, 2020
·
7 min read
Drug Development

Blueprint Medicines Announces Part 1 Results from PIONEER Trial Showing Broad Activity of Avapritinib Across Measures of Mast Cell Burden, Clinical Outcomes and Quality of Life in Indolent Systemic Mastocytosis

Blueprint Medicines Corporation today announced updated results from the Phase 2 pioneer trial.

March 16, 2020
·
13 min read